Micro-patterned drug delivery device for light-activated drug release

Lasers in Surgery and Medicine

Volumn 44, Issue 1, 2012, Pages 30-48

  Zaman, Raiyan T ^a   Gopal, Ashwini ^b   Starr, Kathryn ^c   Zhang, Xiaojing ^c   Thomsen, Sharon ^d   Tunnell, James W ^c   Welch, Ashley J ^c   Rylander III, Henry G ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Innovative Micro Technology (IMT)   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d Pathology for Physicists and Engineers   (United States)

Author keywords

100 anhydrous glycerol; drug delivery device; fluorescence spectrometer; hyperosmotic agent; Nd:YAG laser; optical clearing

Indexed keywords

DIMETICONE; DYE; FLUORESCEIN SODIUM; GLYCEROL; POLYMER; POLYURETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONJUNCTIVA; DEVICES; DRUG DELIVERY SYSTEM; DRUG RELEASE; EYE; FLUORESCENCE; HISTOLOGY; LIGHT; LIGHT SCATTERING; NEODYMIUM LASER; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCLERA; SPECTROPHOTOMETER;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EYE; FEMALE; FLUORESCEIN; MONTE CARLO METHOD; RABBITS; RANDOM ALLOCATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84862930870     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21149     Document Type: Article

References (62)

1. Li Y, Shawgo RS, Tyler B, Henderson PT, Vogel JS, Rosenberg A, Storm PB, Langer R, Brem H, Cima MJ,. In vivo release from a drug delivery MEMS device. J Control Release 2004; 100: 211-219. (Pubitemid 39491273)
2. Kost AJ, Langer R,. Responsive polymeric delivery systems. Adv Drug Deliv Rev 1991; 6: 19-50.
3. Wu BM, Borland SW, Giordano RA, Cima LG, Sachs EM, Cima MJ,. Solid free-form fabrication of drug delivery devices. J Control Release 1996; 40: 77-87. (Pubitemid 26199192)
4. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ,. Oral dosage forms fabricated by three dimensional printing. J Control Release 2000; 66: 1-9. (Pubitemid 30116679)
5. Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, Cima MJ,. Multimechanism oral dosage forms fabricated by three dimensional printing. J Control Release 2000; 66: 11-17. (Pubitemid 30116680)
6. Santoro N,. Efficacy and safety of intravenous pulsatile gonadotropin-releasing hormone: Lutrepulse for injection. Am J Obstet Gynecol 1990; 163: 1759-1764.
7. Creasy GW, Jaffe ME,. Pulsatile delivery systems. Ann NY Acad Sci 1991; 618: 548-557.
8. Creasy GW, Jaffe ME,. Endocrine/reproductive pulsatile delivery systems. Adv Drug Deliv Rev 1991; 6: 51-56.
9. Sampath P, Brem H,. Implantable slow-release chemotherapeutic polymers for the treatment of malignant brain tumors. Cancer Control 1998; 5: 130-137. (Pubitemid 28178234)
10. Arky R, editor. Physician's desk reference. Montvale, NJ, USA: Medical Economics Company; 1998. pp 2587-2589.
11. Arky R, editor. Physician's desk reference. Montvale, NJ, USA: Medical Economics Company; 1998. pp 3139-3150.
12. Brown L, Langer R,. Transdermal delivery of drugs. Ann Rev Med 1988; 39: 221-229. (Pubitemid 19090797)
13. Siegel RA, Falamarzian M, Firestone BA, Moxley BC,. pH-cobtrolled release from hydrophobic/polyelectrolyte copolymer hydrogels. J Control Release 1988; 8: 179-182. (Pubitemid 19010924)
14. Kim JH, Kim JY, Lee YM, Kim KYJ,. Controlled release of riboflavin and insulin through crosslinked poly (vinyl alcohol)/chitosan blend membrane. Appl Polym Sci 1992; 44: 1823-1828.
15. Gutowska A, Bark JS, Kwon IC, Bae YH, Cha Y, Kim SW,. Squeezing hydrogels for controlled oral drug delivery. J Control Release 1997; 48: 141-148. (Pubitemid 27401972)
16. Bae YH, Okano T, Hsu R, Kim SW,. Thermo-sensitive polymers as on-off switched for drug release. Makromol Chem Rapid Commun 1987; 8: 481-485.
17. Hoffman AS, Afrassiabi A, Dong LC,. Thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions. J Control Release 1986; 4: 213-222. (Pubitemid 17204846)
18. Okano T, Bae YH, Kim SW,. Chapter 2: Temperature responsive controlled drug delivery. In:, Kost J, editor. Pulsed and self-regulated drug delivery. Boca Raton, FL, USA: CRC Press; 1990. pp 17-45.
19. Kwon IC, Bae YH, Kim SW,. Electrically erodible polymer gel for controlled release of drugs. Nature 1991; 354: 291-293. (Pubitemid 21896877)
20. Bae YH, Kwon IC, Kim SW,. In:, Ottenbrite RM, editor. Polymeric drugs and drug administration. Washington, DC, USA: American Chemical Society; 1994. pp 98-110.
21. Milner LL,. Electrochemically controlled release of drug ions from conducting polymers. Mol Cryst Liq Cryst 1998; 160: 297-301.
22. Hepel M, Fijalek Z,. Chapter 7: Electrorelease of drugs from composite polymer films. In:, Ottenbrite RM, editor. Polymetric drugs and drug administration. Washington, DC, USA: American Chemical Society; 1994. pp 79-97.
23. Schwendeman SF, Amidon GL, Levy RJ,. Determinants of the modulated release of antiarrhythmic drugs by iontophoresis through polymer membranes. Macromolecules 1993; 26: 2264-2272.
24. Kost J, Lander R,. Chapter 1: Magnetically and ultrasonically modulated drug delivery systems. In:, Kost J, editor. Pulsed and self-regulated drug delivery. Boca Raton, FL, USA: CRC Press; 1990. pp 3-16.
25. Edelman ER, Kost J, Bobeck H, Langer R,. Regulation of drug release from polemer matrices by oscillating magnetic fields. J Biomed Matter Res 1985; 19: 67-83. (Pubitemid 15130554)
26. Kost J, Leong K, Lander R,. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc Natl Acad Sci USA 1989; 86: 7663-7666.
27. Fischel-Ghodsian F, Brown L, Mathiowitz E, Brandenburn D, Lander R,. Enzymatically controlled drug delivery. Proc Natl Acad Sci USA 1988; 85: 2403-2406. (Pubitemid 24315901)
28. Mathiowitz E, Cohen MD,. Polyamide microcapsules for controlled release. V. photochemical release. J Membr Sci 1989; 40: 67-86.
29. Suzuki Y, Tanihara M, Nishimuru Y, Suzuki K, Kakimaru Y, Shimizu Y,. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Appl Biomat 1998; 42: 112-116. (Pubitemid 28413003)
30. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200-1209.
31. Gragoudas ES, Adamis AP, Cunningham ET, Jr., Feinsod M, Guyer DR,. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-2816. (Pubitemid 40051904)
32. D'Amico DJ, Masonson HN, Patel M, Adamis AP, Cunningham ET, Guyer DR, Katz B,. Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 2006; 113: 992-1001.
33. Ahmed I, Patton TF,. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 1985; 26: 584-587. (Pubitemid 15059025)
34. Geroski DH, Edelhauser HF,. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 2000; 41 (5): 961-964. (Pubitemid 30187528)
35. Fraunfelder FT,. National registry for drug-induced ocular side effects. JAMA 1977; 237 (5): 446. (Pubitemid 8034527)
36. Fraunfelder FT,. Interim report: National registry of possible drug-induced ocular side effects. Ophthalmology 1979; 86 (1): 126-130. (Pubitemid 9171545)
37. Fraunfelder FT,. Interim report: National registry of possible drug-induced ocular side effects. Ophthalmology 1980; 87 (2): 87-90. (Pubitemid 10113531)
38. Fraunfelder FT,. National registry of drug-induced ocular side effects. J Am Ophthalmol 1990; 110 (4): 426-427. (Pubitemid 20355088)
39. Stephenson RW,. Anatomy, physiology and optics of the eye: A textbook for orthoptic students. 2nd edition. London: Kimpton Publishers; 1973.
40. Zaman RT, Nichols BS, Rylander HG III, Wang T, Tunnell JW, Welch AJ,. Changes in morphology and optical properties of sclera and choroidal layers due to hyperosmotic agent. J Biomed Opt 2011; 16 (7): 77008-1-77008-14.
41. Lens A, Nemeth SC, Ledford JK,. Ocular anatomy and physiology. Thorofare NJ: Slack Incorporated Publishers; 2007.
42. Feng Y, Simpson TL,. Corneal, limbal, and conjunctival epithelial thickness from optical coherence tomography. Optom Vis Sci 2008; 85 (9): 880-883.
43. Hayreh SS,. Segmental nature of the choroidal vasculature. Br J Ophthalmol 1975; 59 (11): 631-648.
44. Young AR,. Chromophores in human skin. Phys Med Biol 1997; 42 (5): 789-802. (Pubitemid 27263500)
45. Agency for Toxic Substances and Disease Registry ToxFAQs, 1,1-dicholoroethene CAS#75-35-4, 1-2 (1995).
46. Agency for Toxic Substances and Disease Registry, Technical Factsheet on: 1,1-dichloroethylene, 1-3 (1993).
47. Anderson J, Chiu D, Jackman R, Cherniavskaya O, McDonald J, Wu H, Whitesides S, Whitesides G,. Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Science 1993; 261: 895.
48. McDonald J, Duffy D, Anderson J, Chiu D, Wu H, Schueller O, Whitesides G,. Fabrication of microfluidic systems in poly (dimethylsiloxane). Electrophoresis 2000; 21 (1): 27-40. (Pubitemid 30032694)
49. Wägli P, Homsy A, de Rooij NF,. Norland optical adhesive (NOA81) microchannels with adjustable wetting behavior and high chemical resistance against a range of mid-infrared-transparent organic solvents. Sensor Actuat B 2011; 156: 994-1001.
50. Norland Optical Adhesive 68 MSDS, Material safety data sheet, 1-5 (1997).
51. Keijzer M, Jacques SL, Prahl SA, Welch AJ,. Light distribution in artery tissue: Monte Carlo simulations for finite diameter laser beams. Lasers Surg Med 1989; 9: 148-154. (Pubitemid 19119404)
52. Jacques SL, Alter CA, Prahl SA,. Angular dependence of HeNe laser light scattering by human dermis. Lasers Life Sci 1987; 1: 309-333.
53. Nemati B, Dunn A, Welch AJ, Rylander HG,. Optical model for light distribution during transscleral cyclophotocoagulation. Appl Opt 1998; 37 (4): 764-771. (Pubitemid 128657311)
54. Huges A,. A schematic eye for the rabbit. Vision Res 1972; 12: 123-138.
55. Lo R, Li P-Y, Saati S, Agrawal RN, Humayun MS, Meng E,. A passive MEMS drug delivery pump for treatment of ocular diseases. Biomed Microdevices 2009; 11: 959-970.
56. Lo R, Kuwahara K, Li P-Y, Agrawal R, Humayun MS, Ellis Meng,. A passive refillable intraocular MEMS drug delivery device, Proceedings of 2006 International Conference on Microtechnologies in Medicine and Biology Okinawa, Japan, May 9-12, 2006.
57. Meyers RA,. Molecular biology biotechnology: A comprehensive desk reference. Danvars, MA: Wiley-VCH; 1995. p 722.
58. Miller M,. Review of orthopedics, 4th edition. Philadelphia: W. B. Saunders; 1996. p 129. ISBN 0721659012.
59. Lavanya R, Teo L, Friedman DS, Aung HT, Baskaran M, Gao H, Alfred T, Seah SK, Kashiwagi K, Foster PJ, Aung T,. Comparison of anterior chamber depth measurements using the IOLMaster, scanning peripheral anterior chamber depth analyser, and anterior segment optical coherence tomography. J Ophthalmol 2007; 91: 1023-1026. (Pubitemid 47122106)
60. Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V,. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 2005; 46: 726-733. (Pubitemid 40270359)
61. McLaren JW, Brubaker RF,. A Scanning ocular specfrofluorophotometer. Invest Ophthalmol Vis Sci 1988; 29 (8): 1285-1293.
62. Delori FC, Castany MA, Webb RH,. Fluorescence characteristics of sodium fluorescein in plasma and whole blood. Exp Eye Res 1978; 27: 417.